TY - JOUR
T1 - Echocardiographic Deformation Imaging for Early Detection of Genetic Cardiomyopathies
T2 - JACC Review Topic of the Week
AU - Taha, Karim
AU - Kirkels, Feddo P.
AU - Teske, Arco J.
AU - Asselbergs, Folkert W.
AU - van Tintelen, J. Peter
AU - Doevendans, Pieter A.
AU - Kutty, Shelby
AU - Haugaa, Kristina H.
AU - Cramer, Maarten J.
N1 - Funding Information:
This work was supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation (2015-12 eDETECT; 2018-30 PREDICT2), the PLN Genetic Heart Disease Foundation, the Leducq Foundation (CurePLaN consortium), and the Norwegian research council (ProCardio, Grant #309762). Dr Asselbergs was supported by University College London Hospitals NIHR Biomedical Research Centre. Dr Kutty has served as a consultant for GE Healthcare and as a scientific advisor for OP2 Drugs. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2022 American College of Cardiology Foundation
PY - 2022/2/15
Y1 - 2022/2/15
N2 - Clinical screening of the relatives of patients with genetic cardiomyopathies is challenging, as they often lack detectable cardiac abnormalities at presentation. Life-threatening adverse events can already occur in these early stages of disease, so sensitive tools to reveal the earliest signs of disease are needed. The utility of echocardiographic deformation imaging for early detection has been explored for this population in multiple studies but has not been broadly implemented in clinical practice. The authors discuss contemporary evidence on the utility of deformation imaging in relatives of patients with genetic cardiomyopathies. The available body of data shows that deformation imaging reveals early disease-specific abnormalities in dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy. Deformation imaging seems promising to enhance the screening and follow-up protocols in relatives, and the authors propose measures to accelerate its implementation in clinical care.
AB - Clinical screening of the relatives of patients with genetic cardiomyopathies is challenging, as they often lack detectable cardiac abnormalities at presentation. Life-threatening adverse events can already occur in these early stages of disease, so sensitive tools to reveal the earliest signs of disease are needed. The utility of echocardiographic deformation imaging for early detection has been explored for this population in multiple studies but has not been broadly implemented in clinical practice. The authors discuss contemporary evidence on the utility of deformation imaging in relatives of patients with genetic cardiomyopathies. The available body of data shows that deformation imaging reveals early disease-specific abnormalities in dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy. Deformation imaging seems promising to enhance the screening and follow-up protocols in relatives, and the authors propose measures to accelerate its implementation in clinical care.
KW - deformation imaging
KW - early detection
KW - family screening
KW - genetic cardiomyopathy
KW - speckle tracking
KW - Echocardiography/methods
KW - Humans
KW - Cardiomyopathies/diagnosis
KW - Early Diagnosis
UR - https://www.scopus.com/pages/publications/85123755422
U2 - 10.1016/j.jacc.2021.11.045
DO - 10.1016/j.jacc.2021.11.045
M3 - Review article
C2 - 35144751
AN - SCOPUS:85123755422
SN - 0735-1097
VL - 79
SP - 594
EP - 608
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 6
ER -